GLPGF OTC
Lakefront Biotherapeutics
1W: +0.0%
1M: +21.8%
3M: +13.8%
YTD: +2.1%
1Y: -4.5%
3Y: -19.1%
5Y: -72.8%
$31.95
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$990M
Revenue
+259.3% YoY
$596M
Net Income
+309.8% YoY
$-174M
Free Cash Flow
+41.5% YoY
24.9%
Gross Margin
-366.2%
Op. Margin
17.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE20.2%
ROA16.6%
ROIC39.4%
Valuation
P/E3.5
P/B0.5
EV/EBITDA0.0
Leverage
Debt/Equity0.00
Current Ratio32.82
Interest Cov.17.8x
Quality Scores
Piotroski F5/9
Altman Z—
Beneish M1.23